Padagis Trospium Capsules Recall: Missing Tablets in Capsules
Padagis recalls 60mg Trospium Chloride Extended-Release Capsules due to missing/broken tablets inside capsules. Rx-only medication distributed by Padagis in the US.
Lower-risk recall
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
Contact the company
What happened, in plain English
Padagis is recalling 60mg Trospium Chloride Extended-Release Capsules (30 capsules per bottle) because some capsules contain missing, broken, or extra tablets. This could cause inconsistent dosing if taken as prescribed. Read more at govinfonow.com/recall/33015-padagis-trospium-capsules-recall-missing-tablets-in-capsules.
Source Summary by GovInfoNow · govinfonow.com/recall/33015-padagis-trospium-capsules-recall-missing-tablets-in-capsules · Updated September 23, 2026 · FDA enforcement record: FDA #D-0139-2024
Cite this page
“Padagis Trospium Capsules Recall: Missing Tablets in Capsules.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33015-padagis-trospium-capsules-recall-missing-tablets-in-capsules. Based on FDA recall #D-0139-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0139-2024%22&limit=1).
Why it’s dangerous
The capsules may contain missing, broken, or extra tablets. This could lead to inconsistent dosing if taken as prescribed, potentially affecting treatment effectiveness.
Who’s affected
People who have prescription Trospium Chloride Extended-Release Capsules (60mg, 30-count) from Padagis in the US. Those with specific lot numbers (231104-231106) are most at risk.
How to tell if you have this one
Check for the product name 'Trospium Chloride Extended-Release Capsules', 60mg, 30 capsules per bottle. Look for lot numbers 231104, 231105, or 231106 with expiration date 7/31/2025.
- Brand
Padagis- Category
Drug
What to do — step by step
Check Capsule Integrity
Inspect each capsule for missing, broken, or extra tablets before use.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 42 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Padagis recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0139-2024 (November 1, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0139-2024 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.